Single-cell sequencing elucidates the mechanism of NUSAP1 in glioma and its diagnostic and prognostic significance
BackgroundPersonalized precision medicine (PPPM) in cancer immunology and oncology is a rapidly advancing field with significant potential. Gliomas, known for their poor prognosis, rank among the most lethal brain tumors. Despite advancements, there remains a critical need for precise, individualize...
Saved in:
Main Authors: | Meng-Yu Zhao, Zhao-Lei Shen, Hongzhen Dai, Wan-Yan Xu, Li-Na Wang, Yu- Gu, Jie-Hui Zhao, Tian-Hang Yu, Cun-Zhi Wang, Jia-feng Xu, Guan-Jun Chen, Dong-Hui Chen, Wen-Ming Hong, Fang Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-02-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1512867/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Single-cell sequencing uncovers the mechanistic role of DAPK1 in glioma and its diagnostic and prognostic implications
by: Tian-Hang Yu, et al.
Published: (2025-01-01) -
The role of VANGL2 in glioma oncogenesis and progression: insights into expression profiles and prognostic relevance
by: Mingyu Zhao, et al.
Published: (2025-01-01) -
TERTp Mutation and its Prognostic Value in Glioma Patients Under the 2021 WHO Classification: A Real‐World Study
by: Hao Xing, et al.
Published: (2025-01-01) -
Development and Validation of a Prognostic Molecular Phenotype and Clinical Characterization in Grade III Diffuse Gliomas Treatment with Radio-Chemotherapy
by: Gu W, et al.
Published: (2025-01-01) -
Application of Multifunctional Metal Nanoparticles in the Treatment of Glioma
by: Ren Y, et al.
Published: (2025-01-01)